Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics

Daniil Sokolov, Neha Sharda, Aindrila Banerjee, Kseniia Denisenko, Emad B. Basalious, Hem Shukla, Jaylyn Waddell, Nadia M. Hamdy, Aditi Banerjee

Open source

DOI: 10.2174/0113816128277350231219062154
Published: 2024-01
Container: Current Pharmaceutical Design
Publisher: Bentham Science Publishers Ltd.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0113816128277350231219062154,
  title = {Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting
Non-coding Epigenetics to Improve Current and Future Therapeutics},
  author = {Daniil Sokolov and Neha Sharda and Aindrila Banerjee and Kseniia Denisenko and Emad B. Basalious and Hem Shukla and Jaylyn Waddell and Nadia M. Hamdy and Aditi Banerjee},
  year = {2024},
  journal = {Current Pharmaceutical Design},
  doi = {10.2174/0113816128277350231219062154},
  url = {https://doi.org/10.2174/0113816128277350231219062154}
}

RIS

TY  - JOUR
TI  - Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting
Non-coding Epigenetics to Improve Current and Future Therapeutics
AU  - Daniil Sokolov
AU  - Neha Sharda
AU  - Aindrila Banerjee
AU  - Kseniia Denisenko
AU  - Emad B. Basalious
AU  - Hem Shukla
AU  - Jaylyn Waddell
AU  - Nadia M. Hamdy
AU  - Aditi Banerjee
PY  - 2024
JO  - Current Pharmaceutical Design
DO  - 10.2174/0113816128277350231219062154
UR  - https://doi.org/10.2174/0113816128277350231219062154
ER  -

APA

Sokolov, D., Sharda, N., Banerjee, A., Denisenko, K., Basalious, E. B., Shukla, H., Waddell, J., Hamdy, N. M., & Banerjee, A. (2024). Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics. Current Pharmaceutical Design. https://doi.org/10.2174/0113816128277350231219062154

Source records

crossref · retrieved 2026-09-27T07:09:16.175Z